ABSTRACT & COMMENTARY

Beta-blocker Dose More Important Than Heart Rate in Systolic Heart Failure

December 15, 2015

In chronic heart failure with reduced ejection fraction, titrating beta-blocker doses may confer a greater benefit than reducing heart rate.

Issue Date: December 15, 2015

Table of Contents

Financial Disclosure: Internal Medicine Alert’s editor Stephen Brunton, MD, is a retained consultant for Abbott, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, Sanofi, and Teva; he serves on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Contributing editor Louis Kuritzky is a retained consultant for AbbVie, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Chelsea, Daiichi Sankyo, Forest Pharmaceuticals, Janssen, Lilly, Novo Nordisk, Pfizer, and Sanofi. Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements